Methods

Data Collection
The study was approved by the local institutional review board. We reviewed a prospectively maintained database on consecutive patients with UIAs evaluated by the senior author (G.L.) from January 2008 until May 2011. Information collected included demographic data, factors that led to the discovery of the target aneurysm, potential risk factors for intracranial aneurysm formation and rupture (smoking, hypertension, and family history of intracranial aneurysms and aneurysmal SAH), known medical disorders associated with an increased occurrence of UIAs, and aneurysm location, size, and multiplicity. Aneurysm size was measured using digital subtraction angiography when available; otherwise, measurement was obtained from the available CT/MR angiograms.
Inclusion and Exclusion Criteria
For the purpose of this study, patients were considered only if they harbored a UIA ≤ 10 mm in diameter (in patients with multiple aneurysms, the largest one could measure ≤ 10 mm in diameter) and if the aneurysm was discovered incidentally-that is, there was no correlation between symptoms/complaints leading to aneurysm detection and the aneurysm itself. We excluded patients with cranial nerve palsies related to the aneurysm, patients with localized pain that could be referable to the aneurysm (for example, ipsilateral retroorbital pain in patients with posterior communicating artery aneurysms), and patients presenting with ischemic symptoms considered to be possibly related to the aneurysm. Patients with unruptured aneurysms identified during investigation for SAH from another aneurysm were also excluded. Because of the different natural history and the notion that no treatment is indicated in such cases, patients with incidentally found extradural aneurysms located in the cavernous sinus were excluded from further analysis. Only patients with newly discovered aneurysms were considered. Patients with known small incidental aneurysms that had already been followed before by other physicians were excluded. Patients with an aneurysm and associated arteriovenous malformation were excluded. Treatment recommendations and management of this cohort are specified in the accompanying manuscript. 
Statistical Analysis
To determine whether a difference observed between the groups was statistically significant, we used a 2-sided t-test for continuous data and the chi-square test for categorical variables. The Fisher exact test was used when more than 20% of the tables had a value less than 5. All statistical analysis was performed using JMP software version 9.0.1 (SAS Institute Inc.). A predefined p value of 0.05 was considered the cutoff point of statistical significance.
Results
Patient Population
During the study period, the senior author (G.L.) evaluated 335 patients (254 females [75.8%] and 81 males (24.2%]) with 478 small, unruptured saccular aneurysms. Excluded from further analysis were 79 patients (23.6%) with known aneurysms already being followed, 11 patients (3.3%) with unruptured aneurysms found during investigation for SAH from a different aneurysm, 26 patients (7.8%) with small, potentially symptomatic aneurysms, and 2 patients (0.6%) with aneurysms associated with an intracranial arteriovenous malformation. Two hundred seventeen patients (64.8% of the entire cohort) were evaluated for 278 newly discovered incidental small UIAs. Five of these patients only had incidental aneurysms located in the cavernous sinus and were also excluded from further analysis. Thus, 212 patients (63.3%) with 272 small incidental aneurysms are the focus of this study. Reasons for performing the imaging study that led to the discovery of the aneurysms are summarized in Table 1 .
The mean age of the patient population was 60.6 years (median 62 years, range 25-88 years). There were 158 women (74.53%) and 54 men (25.47%). Demographics and potential risk factors for aneurysm formation/growth at the time of presentation are summarized in Table 2 .
Aneurysm Characteristics
The most common aneurysm location was the middle cerebral artery and the second most common location was the paraclinoid region of the ICA and the anterior communicating artery-anterior cerebral artery complex. Aneurysm characteristics are summarized in Table 3 . The mean size of the aneurysms was 5.5 mm (in patients with multiple aneurysms, only the largest aneurysm was considered for this calculation).
Discussion
With the widespread use of noninvasive imaging tech- niques, small incidentally found UIAs are detected with increasing frequency. More commonly these aneurysms are detected in patients undergoing imaging evaluation for illdefined spells and symptoms related to focal cerebrovascular ischemia (43%). Other common reasons for performing an imaging study, which in turn leads to the discovery of a small aneurysm, include evaluation for a known or probable intracranial and neck lesion (24%), as well as headache/ migraine not related to the aneurysm (16%). When a small intracranial aneurysm is detected, the treating physician is often left with a significant management dilemma. The majority of small aneurysms probably endure without rupture. However, the risk of rupture is not nil, and more importantly, when aneurysms do rupture, the prognosis is poor. Ill-defined spells, symptoms of focal cerebrovascular ischemia, and known or probable intracranial or neck pathology are more common with advanced age, and a large number of intracranial aneurysms are diagnosed in elderly individuals. This is reflected in the age (mean 60.6 years, median 62 years) of patients with small incidental intracranial aneurysms in our series. Advanced age is a factor associated with a higher risk of complications from treatment. 8 Elderly patients are also less likely to benefit from treatment because of their shorter life expectancy and the lesion's low annual risk of rupture. Diagnosis of a small incidental UIA in patients of advanced age is not uncommon. Invasive treatment, however, should be considered only in selected cases. Many patients with UIAs are already receiving or may need anticoagulation or antiplatelet therapy, given the high incidence of cardiovascular disorders. In such cases, we recommend proceeding with anticoagulation or antiplatelet therapy if clinically indicated irrespective of the status (treated or untreated) of the aneurysm. This recommendation is based on the very benign natural history of small unruptured incidental aneurysms and on the fact that anticoagulation or antiplatelet therapy per se does not increase the risk of aneurysm rupture. In no case did the need of starting antiplatelet or anticoagulation therapy influence our recommendation for management of the aneurysm. Smoking and hypertension are known risk factors for aneurysm formation and rupture. 4, 6, 7 In our series, 68% of patients were either current or past smokers and 60% had known hypertension. In patients who are cigarette smokers, appropriate counseling and medical managements strategies should be implemented to increase the likelihood of smoking cessation. Elevation in blood pressure consistent with hypertension should be treated to attain normal blood pressure levels and should be monitored closely over time. It is noteworthy that in part because of the association of smoking and hypertension with intracranial aneurysms, the overall long-term health of these patients is mostly influenced by the development of cardiovascular disease and cancer rather than rupture of the aneurysm. Therefore, smoking cessation and control of hypertension and other atherosclerosis risk factors may be as effective as successful treatment of the aneurysm. In our series, only 4% of aneurysms were discovered during screening based on a familial history of aneurysms. However, 23% of patients had a history of intracranial aneurysms with or without SAH in at least one relative. Patients with a family history of aneurysmal SAH are often quite distressed by the knowledge of having an intracranial aneurysm because they have witnessed the sequelae of aneurysmal rupture. In these patients, invasive treatment of the aneurysm is often considered because of the stress and the effects on the patient's quality of life. Moreover, preliminary data from the Familial Intracranial Aneurysm study 1 may suggest a more aggressive natural history for small intracranial aneurysms in first-degree relatives of patients with aneurysmal SAH. The location distribution of small incidental UIAs is slightly different than the distribution of small ruptured aneurysms. In particular, there is a preponderance of paraclinoid aneurysms (approximately 22% of the total, after excluding extradural intracavernous aneurysms) while these aneurysms, especially when small, are uncommon in patients with aneurysmal SAH. 3, 5 This observation may suggest that the natural history of small paraclinoid aneurysms may be more benign than small aneurysms in other locations, and aneurysm location should be considered when making treatment recommendations. Such difference in rupture rate by UIA location has been noted in large natural history studies, when considering aneurysms of all locations and sizes. 8 
Conclusions
In our study, small incidental UIAs were more commonly diagnosed in elderly individuals during imaging studies obtained for investigation of ill-defined spells and symptoms related to focal cerebrovascular ischemia, or for the evaluation of known or probable other intracranial/neck pathological entities. Hypertension, smoking, and family history of intracranial aneurysm or SAH are quite common in this patient population, and the presence of these risk factors has important implications for treatment recommendations. Although paraclinoid aneurysms (excluding intracavernous aneurysms) are quite uncommon among patients with ruptured intracranial aneurysms, this location is the most common in patients with small incidental UIAs.
